The Brock Family Center for Applied Innovation at VUMC is facilitating this collaboration. The data-derived knowledge will address unmet medical needs across many diseases,” said Jennifer Pietenpol, PhD, Chief Scientific and Strategy Officer for VUMC and holder of the Brock Family Directorship. Importantly, VUMC’s de-identified clinical data is maintained in a secure VUMC environment that allows our investigators and companies to develop and use algorithm models for innovation. “Joining with nference is a VUMC strategic initiative to improve health care for patients everywhere through accelerated discoveries derived from our de-identified electronic health data. Implementing Pramana’s digital pathology solution allows VUMC researchers to access a new modality of digitized patient data. As part of this agreement, Pramana, a nference company modernizing the pathology sector, will lead efforts to digitize VUMC’s glass pathology slides across oncology, cardiovascular and metabolic diseases. Leveraging multimodal data, including imaging and digital pathology, offers a holistic view of complex diseases. “nference’s advanced capability to utilize information gathered from electronic health records, imaging data, and digital pathology data, when combined with our historic and deep experience and leadership in biomedical informatics and health information technology, allows us to advance the understanding of devastating diseases while accelerating biomedical research,” said Jeff Balser, MD, PhD, President and Chief Executive Officer for VUMC and Dean of Vanderbilt University School of Medicine. The agreement highlights both nference and VUMC’s commitment to using the most advanced technology to accelerate medical research and improve patient care. This platform will provide Vanderbilt researchers and others in the life sciences community with an increasingly diverse dataset, which is crucial in understanding and addressing the varied patient needs across the healthcare spectrum. By leveraging the power of federated AI and machine learning, this collaboration will expand clinical insights in key research areas.Ĭombining VUMC’s extensive longitudinal, multi-modal data with nference’s federated AI platform will enable both parties to advance real-world scientific insights for drug discovery and patient care. Nference, a science-first software company transforming health care by making biomedical data computable, and Vanderbilt University Medical Center, a leading academic medical center, have announced a strategic agreement aimed at advancing research through the deployment of nference’s state-of-the-art federated clinical analytics platform.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |